Haemonetics Corp (NYSE:HAE) reported upbeat earnings for the first quarter on Thursday.
The company posted quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $1.02 per share. The company reported quarterly sales of $321.394 million which beat the analyst consensus estimate of $305.115 million.
Haemonetics affirmed FY2026 adjusted EPS guidance of $4.70 to $5.00.
Haemonetics shares closed at $55.63 on Thursday.
These analysts made changes to their price targets on Haemonetics following earnings announcement.